In dormant cells of murine melanoma, GILZ signaling antagonizes cell quiescence and induces cell cycle reactivation and tumor development, but GILZ repression induces cellular quiescence and contributes to melanoma inactivity [28]. Here, TSC22D3 is linked to neoplasm.